1st human application of CRISPR could end sickle cell disease – Daily Californian
1st human application of CRISPR could end sickle cell diseaseDaily CalifornianThe breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by Jennifer Doudna, a UC Berkeley professor of biochemistry and molecular biology, may soon be a… Continue reading
